共 50 条
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu's arteritis: a case report and review of the literature
被引:0
|作者:
Liang, Shichu
[1
]
Yang, Jinming
[2
]
Ma, Min
[1
]
Zhou, Minggang
[1
]
Liu, Zhiyue
[1
]
Huang, He
[1
]
He, Yong
[1
]
机构:
[1] Sichuan Univ, West China Hosp, Dept Cardiol, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu, Peoples R China
基金:
中国博士后科学基金;
关键词:
Takayasu's arteritis;
Excimer laser coronary atherectomy;
Drug-coated balloon;
Anti-inflammation;
IN-STENT RESTENOSIS;
ELUTING STENT;
AMERICAN-COLLEGE;
STENOSIS;
INTERVENTION;
OUTCOMES;
PATIENT;
D O I:
10.1186/s12959-023-00529-9
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Takayasu's arteritis (TAK) is a rare chronic granulomatous arteritis that mainly affects the aorta and its major branches. Coronary artery (CA) involvement can be observed in 10-25% of TAK patients. We report a 21-year-old young female who was previously diagnosed with TAK and severe left main coronary artery (LMCA) stenosis and underwent numerous percutaneous coronary interventions (PCIs) in our hospital due to in-stent restenosis (ISR). This time, an excimer laser coronary atherectomy (ELCA) and drug-coated balloon (DCB) dilation was taken at the LMCA for the ISR. The blood flow was smooth after the operation, and she was symptom-free after discharge. Unfortunately, 5 months later, severe intimal hyperplasia was still seen in the stent of LMCA and left anterior descending (LAD) coronary artery. A coronary artery bypass graft surgery (CABG) was performed, and she has been symptom-free ever since. ELCA plus DCB is one of the novel ways we first reported. However, ensuring long-term inflammation control is equally important to restore blood flow. The combination of revascularization and anti-inflammation/immunosuppression is recommended to improve the outcomes of TAK patients with CA involvements.
引用
收藏
页数:10
相关论文